Virtual Event | December 19, 2022

Challenges with Bioassays

Source: Cytiva

Gregory Opiteck, Ph.D., VP Head of Translational Sciences at Allogene Therapeutics talks the audience through bioassay challenges in cell therapy, particularly the PK assay. Douglas Sanders, Ph.D., VP Head of Translational Medicine at AVROBIO explains why it is a challenge to get appropriate samples for assay development and validation.

VIEW THE VIRTUAL EVENT!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Cell & Gene

Please tell us more about you so that we can customize our newsletters to your specific interests:

Cytiva